BioCentury
ARTICLE | Financial News

MorphoSys gains on financial results, outlook

March 3, 2016 1:53 AM UTC

MorphoSys AG (Xetra:MOR) gained EUR 4.01 (11%) to EUR 41.72 on Wednesday after reporting 4Q15 and 2015 financial results, including revenues for the year that came in slightly above its guidance.

MorphoSys reported EUR 106.2 million ($116 million) in 2015 revenues and EBIT of EUR 17.2 million ($18.8 million). Last March, the company had guided to full-year revenues of EUR 101-EUR 106 million and EBIT of EUR 9-EUR 16 million. ...